BRAF mutation as a prognostic marker for survival in malignant melanoma: A systematic review and meta-analysis.

被引：7

作者：

Ny, Lars

Nyakas, Marta

Hernberg, Micaela

Koivunen, Jussi

Oddershede, Lars

Yoon, Mie-Ran

Wang, Xuan

Guyot, Patricia

Geisler, Jurgen

机构：

[1] Univ Gothenburg, Dept Oncol, Gothenburg, Sweden

[2] Norwegian Radium Hosp, Oslo Univ Hosp, Oslo, Norway

[3] Helsinki Univ Hosp, Ctr Comprehens Canc, Helsinki, Finland

[4] Univ Oulu, Dept Canc & Radiotherapy, Oulu, Finland

[5] Novartis Healthcare AS, Copenhagen, Denmark

[6] Mapi, Real World Strategy & Analyt, Stockholm, Sweden

[7] Mapi, Real World Strategy & Analyt, Lyon, France

[8] Univ Oslo, Inst Clin Med, Campus AHUS, Oslo, Norway

[9] Akershus Univ Hosp, Dept Oncol, Akershus, Norway

来源：

关键词：

D O I：

10.1200/JCO.2018.36.15_suppl.e21566

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e21566

引用

页数：1